Dermata Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Dermata Therapeutics generated cash of -$6,408,931, which is more than the previous year. Cash used in financing activities reached the amount of $7,605,772 last year. Net change in cash is therefore $1,196,841.
Cash Flow
| 2019 | -3.92M | 0 | 4.73M |
|---|---|---|---|
| 2020 | -4.02M | 0 | 2.56M |
| 2021 | -5.69M | 0 | 15.96M |
| 2022 | -8.83M | 0 | 4.27M |
| 2023 | -6.40M | 0 | 7.60M |
DRMA Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 6.24M | 10.79M | 530.4K | 1.99M | 1.17M |
Operating activities | |||||
Net income | -7.79M | -9.61M | -7.90M | -3.23M | -4.72M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 0 | 0 | 0 | 322 | 1.35K |
Stock-based compensation expense | 522.08K | 930.32K | 1.90M | 0 | 730 |
| Deferred income tax benefit | 522.08K | 930.32K | 1.90M | 0 | 730 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 369.32K | -18.54K | 410.96K | -232.90K | 122.42K |
Cash generated by operating activities | -6.40M | -8.83M | -5.69M | -4.02M | -3.92M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 |
Financing activities | |||||
Common Stock Issued | 7.60M | 4.27M | 15.38M | 268.75K | 5.36M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -40 | 0 | -1M | 0 | 0 |
Repayments of term debt | 0 | 0 | -556.48K | -810.18K | -626.16K |
Cash used in financing activities | 7.60M | 4.27M | 15.96M | 2.56M | 4.73M |
Net Change In Cash | 1.19M | -4.55M | 10.26M | -1.46M | 812.18K |
Cash at end of period | 7.43M | 6.24M | 10.79M | 530.4K | 1.99M |
| Data source | Data source | Data source |